» Articles » PMID: 35326567

Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Mar 25
PMID 35326567
Authors
Affiliations
Soon will be listed here.
Abstract

Pleural effusions are a common respiratory condition with many etiologies. Nonmalignant etiologies explain most pleural effusions and despite being nonmalignant, they can be associated with poor survival; thus, it is important to understand their pathophysiology. Furthermore, diagnosing a benign pleural pathology always harbors the uncertainty of a false-negative diagnosis for physicians and pathologists, especially for the group of non-specific pleuritis. This review aims to present the role of the inflammation in the development of benign pleural effusions, with a special interest in their pathophysiology and their association with malignancy.

Citing Articles

Infective Pleural Effusions-A Comprehensive Narrative Review Article.

Abdulelah M, Hishmeh M Clin Pract. 2024; 14(3):870-881.

PMID: 38804400 PMC: 11130797. DOI: 10.3390/clinpract14030068.


Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.

Dadgar N, Sherry C, Zimmerman J, Park H, Lewis C, Donnenberg A J Transl Med. 2024; 22(1):402.

PMID: 38689325 PMC: 11061933. DOI: 10.1186/s12967-024-05205-8.


Anti-Inflammatory Activity of Pequi Oil (): A Systematic Review.

Silva V, Pinheiro A, Ombredane A, Martins N, Luz G, Carneiro M Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38275996 PMC: 10821120. DOI: 10.3390/ph17010011.


Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study.

Zayed N, El Fakharany K, Mehriz Naguib Abozaid M Int J Gen Med. 2022; 15:8705-8713.

PMID: 36575733 PMC: 9790168. DOI: 10.2147/IJGM.S388488.


Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma.

Moro J, Sobrero S, Cartia C, Ceraolo S, Rapana R, Vaisitti F Diagnostics (Basel). 2022; 12(12).

PMID: 36553016 PMC: 9776695. DOI: 10.3390/diagnostics12123009.


References
1.
Henderson D, Shilkin K, Whitaker D . Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol. 1998; 110(3):397-404. DOI: 10.1093/ajcp/110.3.397. View

2.
Karpathiou G, Stefanou D, Froudarakis M . Pleural neoplastic pathology. Respir Med. 2015; 109(8):931-43. DOI: 10.1016/j.rmed.2015.05.014. View

3.
Cheah H, Lansley S, Varano Della Vergiliana J, Tan A, Thomas R, Leong S . Malignant pleural fluid from mesothelioma has potent biological activities. Respirology. 2016; 22(1):192-199. DOI: 10.1111/resp.12874. View

4.
Corcoran J, Culver E, Anstey R, Talwar A, Manganis C, Cargill T . Thoracic involvement in IgG4-related disease in a UK-based patient cohort. Respir Med. 2017; 132:117-121. DOI: 10.1016/j.rmed.2017.10.005. View

5.
Bedawi E, Hassan M, McCracken D, Rahman N . Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics. Expert Rev Respir Med. 2019; 13(4):337-347. DOI: 10.1080/17476348.2019.1578212. View